Somatic clonal evolution: A selection-centric perspective

被引:46
|
作者
Scott, Jacob [1 ]
Marusyk, Andriy [2 ]
机构
[1] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Imaging & Metab, Tampa, FL USA
来源
关键词
Cancer; Initiation; Progression; Natural selection; Selective pressures; Driver; CHROMOSOMAL INSTABILITY; DRUG-RESISTANCE; TUMOR-GROWTH; INTRATUMOR HETEROGENEITY; COMBINATION THERAPY; DARWINIAN DYNAMICS; TARGETED THERAPY; CANCER GENES; DNA-DAMAGE; CELL;
D O I
10.1016/j.bbcan.2017.01.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is generally accepted that the initiation and progression of cancers is the result of somatic clonal evolution. Despite many peculiarities, evolution within populations of somatic cells should obey the same Darwinian principles as evolution within natural populations, i.e. variability of heritable phenotypes provides the substrate for context-specific selection forces leading to increased population frequencies of phenotypes, which are better adapted to their environment. Yet, within cancer biology, the more prevalent way to view evolution is as being entirely driven by the accumulation of "driver" mutations. Context-specific selection forces are either ignored, or viewed as constraints from which tumor cells liberate themselves during the course of malignant progression. In this review, we will argue that explicitly focusing on selection forces acting on the populations of neoplastic cells as the driving force of somatic clonal evolution might provide for a more accurate conceptual framework compared to the mutation-centric driver gene paradigm. Whereas little can be done to counteract the "bad luck" of stochastic occurrences of cancer-related mutations, changes in selective pressures and the phenotypic adaptations they induce can, in principle, be exploited to limit the incidence of cancers and to increase the efficiency of existing and future therapies. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 150
页数:12
相关论文
共 50 条
  • [41] Context-dependent selection as the keystone in the somatic evolution of cancer
    Vibishan, B.
    Watve, Milind G.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] Context-dependent selection as the keystone in the somatic evolution of cancer
    B. Vibishan
    Milind G. Watve
    Scientific Reports, 10
  • [43] On clonal selection
    McEwan, Chris
    Hart, Emma
    THEORETICAL COMPUTER SCIENCE, 2011, 412 (06) : 502 - 516
  • [44] Somatic mutations and clonal evolution in normal blood cells in patients with cancer predisposition syndromes
    Yoshida, Kenichi
    Campbell, Peter
    CANCER SCIENCE, 2024, 115 : 1120 - 1120
  • [45] The evolution of multispecies populations: a multilevel selection perspective
    Lean, Christopher H.
    Jones, Christopher J.
    BIOLOGY & PHILOSOPHY, 2023, 38 (05)
  • [46] The evolution of multispecies populations: a multilevel selection perspective
    Christopher H. Lean
    Christopher J. Jones
    Biology & Philosophy, 2023, 38
  • [47] Dynamic function optimisation: Comparing the performance of clonal selection and evolution strategies
    Walker, JH
    Garrett, SM
    ARTIFICIAL IMMUNE SYSTEMS, PROCEEDINGS, 2003, 2787 : 273 - 284
  • [48] Immune memory and gene library evolution in the dynamic clonal selection algorithm
    Kim J.
    Bentley P.
    Genetic Programming and Evolvable Machines, 2004, 5 (4) : 361 - 391
  • [49] POTENTIAL ROLE FOR ANTIGEN SELECTION IN THE CLONAL EVOLUTION OF BURKITTS-LYMPHOMA
    JAIN, R
    RONCELLA, S
    HASHIMOTO, S
    CARBONE, A
    DICELLE, PF
    FOA, R
    FERRARINI, M
    CHIORAZZI, N
    JOURNAL OF IMMUNOLOGY, 1994, 153 (01): : 45 - 52
  • [50] Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection
    Mondia, Mark Willy L.
    Kritselis, Michael A.
    Donahue, John E.
    Elinzano, Heinrich
    Sarangi, Sasmit
    Bryant, David
    Capelletti, Marzia
    Korn, W. Michael
    Yu, Esther
    Yan, Sherry
    Toms, Steven A.
    Wong, Eric T.
    FRONTIERS IN NEUROLOGY, 2023, 13